Combat Medical Ltd
United Kingdom
- St Albans, Hertfordshire
- 13/03/2026
- Series A
- $3,472,639
Innovative medical device company and manufacturers of the COMBAT BRS (Bladder) and COMBAT PRS (Peritoneal) systems. The BRS delivers HIVEC- Hyperthermic Intra-Vesical Chemotherapy treatment through a closed self regulating recirculation system to significantly increase the effectiveness of Mitomycin C (MMC) in Non Muscle Invasive Bladder Cancer (NMIBC). The PRS delivers HIPEC+ Agitation - Hyperthermic Intraperitoneal Chemotherapy plus agitation to optimise the HIPEC delivery while treating cancers within the peritoneal cavity including ovarian, colo -rectal, pancreatic and gastric.
See our website for recently presented clinical evidence on over 500 patients.
Both devices have been in clinical use since 2011 and we invest heavily in Clinical trials and R&D to prove our technology.
Please see www.combat-medical.com or contact us on +44 1582 834466 for centres offering Hyperthermic Device Assisted Technology with the COMBAT BRS and PRS systems throughout Europe or to find out more about our extensive clinical programme.
- Industry Medical Equipment Manufacturing
- Website https://combatcancer.com/
- LinkedIn https://www.linkedin.com/company/combat-medical-ltd/
Related People
Edward Bruce-WhiteFounder
United Kingdom -
treatments through world-leading hyperthermic technologies. St Albans, England
An entrepreneurial CEO with 20+ years’ experience, Edward’s strengths lie in collaborating with some of the brightest doctors, scientists, and engineers and transforming groundbreaking ideas into tangible solutions. Providing strategic guidance, business acumen, and a commercial perspective, he bridges the gap between innovation and market success. Edward has a proven track record of developing and commercialising new products, bringing them to market, and scaling businesses through strategic sales, marketing, and growth initiatives.
• End to end product development
• Medical devices
• Strategic planning
• Turnarounds
• International M&A
• Project management and implementation
• Business and product development
• Corporate restructuring
• Financing
• Persuasive board-level communication
• Creative thinking and agile problem solving
• Regulatory strategy and implementation
Strong track record in helping companies grow through business-development initiatives, introducing new products and technologies, joint ventures, start-ups and creating distribution networks, including:
• Project-managing $330m IPO on Singapore stock exchange
• Researching & identifying new opportunities
• Developing business, strategic and sales & marketing plans
• Leading, negotiating and closing full acquisition deals from start to finish
• Integrating and handling initial management of acquired and new businesses
• Project-managing enterprises with teams of up to 50 people
• Raising funds for start-up ventures
• Raising non dilutive grant funding
Arycs Technologies | $24,000,000 | (Mar 13, 2026)
Ezra(2) | $8,000,000 | (Mar 13, 2026)
Freestyle | $10,000,000 | (Mar 13, 2026)
Mantis Space | $10,000,000 | (Mar 13, 2026)
Monteris Medical | $28,000,000 | (Mar 13, 2026)
Gumloop | $50,000,000 | (Mar 13, 2026)
Qurrent | $15,000,000 | (Mar 13, 2026)
Waiv, formerly Owkin Dx | $33,000,000 | (Mar 13, 2026)
Option Circle | $3,000,000 | (Mar 12, 2026)
AgentMail (YC S25) | $6,000,000 | (Mar 12, 2026)